Serum ceruloplasmin in melanoma patients

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 629-632

  Ros Bullon M R ^a   Sanchez Pedreno P ^a   Martinez Liarte J H ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Ceruloplasmin; Melanoma; ROC analysis; Tumor markers

Indexed keywords

CERULOPLASMIN; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NEPHELOMETRY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

AREA UNDER CURVE; CERULOPLASMIN; HUMANS; MELANOMA; NEOPLASM PROTEINS; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035059548     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tumor markers in cancer diagnosis and prognosis
2. LDH and melanoma
3. Neuron-specific enolase
4. Serum sialic acid in malignant melanoma patients. An ROC curve analysis
5. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma
6. Evaluation of melanin-related metabolites as markers of melanoma progression
7. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxy-indole-2-carboxylic acid as a prognostic marker for malignant melanoma
8. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma
9. Serum zinc levels are increased in melanoma patients
10. Serum tyrosine hydroxylase activity is increased in melanoma patients. An ROC curve analysis
11. Whole blood glutathione peroxidase activity in melanoma patients
12. Serum levels of sICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression
13. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
14. Extracellular copper substituents and mammalian copper transport
15. Transcriptional regulation of ceruloplasmin gene expression during inflammation
16. Caeruloplasmin biosynthesis by the human uterus
17. Tissue-specific ceruloplasmin gene expression in the mammary gland
18. Serum ultrafiltrable copper and caeruloplasmin concentrations in gynaecological carcinomas
19. Serum levels of copper, zinc, iron and ceruloplasmin in oral leukoplakia and squamous cell carcinoma
20. Ceruloplasmin level in women with breast disease. Preliminary results
21. Serum ceruloplasmin as a diagnostic marker of cancer
22. Copper content and the ceruloplasmin activity in the blood in melanoma of the skin
23. The developmental biology of primary human malignant melanomas
24. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
25. MedCalc, a new computer program for medical statistics
26. Basic principles of ROC analysis
27. Receiver-operating characteristics (ROC) plots, a fundamental evaluation tool in clinical medicine
28. The meaning and use of the area under a receiver operating characteristic (ROC) curve
29. Hypothesis for the mechanism of elevated serum copper in cancer patients
30. Ceruloplasmin, copper ions and angiogenesis
31. Changes in the distribution and metabolism of copper in cancer
32. Acute phase reactant proteins. An aid to monitoring surgical treatment of laryngeal carcinoma